Cullinan Therapeutics, Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

14.89

+0.06 (0.40%)

At close: Oct 21, 2026, 4:00 PM EDT

14.70

-0.19 (-1.28%)

Pre-market: Oct 22, 2026, 8:30 AM EDT

Cullinan Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	958	611	709	436	483	674
Market Cap Growth	89.50%	-13.79%	62.69%	-9.73%	-28.36%	-
Enterprise Value	626	280	134	-25	-88	355
Last Close Price	14.89	10.35	12.18	10.19	10.55	15.43

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	4.34	-
Forward PE	-	6.70	6.70	6.70	6.70	-
PS Ratio	-	-	-	-	-	35.58
PB Ratio	2.98	1.50	1.20	0.96	0.90	1.59
P/TBV Ratio	2.98	1.50	1.20	0.96	0.90	1.59

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	-	-	-	18.75

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.01	-
Net Debt / Equity Ratio	-1.03	-0.92	-0.67	-1.02	-0.86	-0.68
Net Debt / EBITDA Ratio	1.50	1.56	2.02	2.44	3.50	4.28
Net Debt / FCF Ratio	2.09	2.13	2.73	3.45	3.62	6.69
Asset Turnover	-	-	-	-	-	0.06
Quick Ratio	8.29	10.09	13.12	16.60	20.77	24.73
Current Ratio	8.42	10.25	13.53	17.07	21.09	25.25
Return on Equity (ROE)	-50.30%	-44.02%	-32.10%	-31.37%	22.74%	-21.57%
Return on Assets (ROA)	-31.36%	-28.23%	-22.26%	-22.80%	-16.55%	-13.03%
Return on Invested Capital (ROIC)	-7446.87%	-212.89%	-214.14%	-601.95%	-91.76%	-108.71%
Return on Capital Employed (ROCE)	-68.60%	-58.80%	-33.30%	-41.80%	-24.50%	-16.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-23.30%	-35.96%	-23.60%	-35.13%	23.03%	-9.73%
FCF Yield	-16.62%	-28.75%	-20.49%	-30.85%	-26.46%	-6.44%
Buyback Yield / Dilution	-2.25%	-9.82%	-29.41%	10.91%	-8.27%	-116.61%

SEC Filings: 10-K · 10-Q